Subscribe

Taiwan Hopax Chems.Mfg.Co.,Ltd. (6509.TWO)

TWD51.10 +0.10 (+0.20%)
TW TWO Basic Materials Chemicals - Specialty
Address No. 28, Huadong Road 831
Kaohsiung, TW
CEO Tsung-Tien Kuo
Website hopax.com.tw
IPO 2007-12-31
ISIN TW0006509003

Explore sections of this company profile

Description

Taiwan Hopax Chemicals Manufacturing Co., Ltd. (Hopax) operates as a global manufacturer and supplier, specializing in a diverse array of chemical solutions. The company's core business encompasses the production and sale of specialty chemicals, fine chemicals, and self-adhesive products, catering to both Taiwanese and international markets. Hopax offers a comprehensive product portfolio designed for various applications. This includes industrial chemicals such as wet end, coating, NCR paper, and dispersant chemicals for paper manufacturing, as well as chemicals for boiler water treatment. Its advanced materials segment features biological buffers, zwitterionic detergents (also known as bio-detergents), and critical additives and electrolytes utilized in electroplating and the production of lithium-ion batteries. Additionally, the company provides sulfonate chain modifiers. Beyond its industrial chemical offerings, Hopax also manufactures a range of consumer products under its well-known Stick'n brand, which falls within its self-adhesive product category. The company serves a broad spectrum of industries, including the chemical, consumer brands, and biopharmaceutical sectors. Established in 1975, Taiwan Hopax Chems.Mfg.Co.,Ltd. is headquartered in Kaohsiung, Taiwan.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
TWD51.10 +0.10 (+0.20%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
4M
Beta
0.44
Float Shares
160.74M
Free Float %
81.8%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-0.20% -1.96% +25.06% +20.53% +43.39% +53.78% +40.56% +13.93% +66.95% +157.48% +301.45%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
51.10
DCF (Unlevered) 93.72 +83.4%
DCF (Levered) 187.84 +267.6%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM)
Rating 2024-11 Change
Strong Buy 0 0
Buy 0 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
3.68
Safe zone
Piotroski F-Score
7 / 9
Strong
MOAT Score
5 / 10
Developing
Composite Rating
A
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
2 / 5
Medium
P/E Score
3 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
  • ✗
    Revenue growth Chemicals - Specialty: +4.7%
    +2.8% Q1'26: +5.3% (vs Q1'25)
  • ✓
    EPS growth Chemicals - Specialty: +13.2%
    +10.4% Q1'26: +52.6% (vs Q1'25)
  • ✓
    FCF margin FCF growth · Chemicals - Specialty: +44.1%
    +14.9% ★ Q1'26: +5.3% (vs Q1'25)
  • ✗
    EBIT margin Chemicals - Specialty: +8.8%
    +16.7% ★ Q1'26: +22.6% (vs Q1'25)
  • ✗
    ROIC Chemicals - Specialty: +5.6%
    +11.1% ★ Q1'26: +19.0% (vs Q1'25)
  • ✗
    Share dilution Chemicals - Specialty: +0.1%
    +2.9% Q1'26: -5.2% (vs Q1'25)
  • ✓
    Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×
    1.40× ★ Q1'26: 0.95× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.49) × ERP
WACC = 86% × Ke + 14% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 93.72 Current price: 51.10
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2017
actual 		Dec 2018
actual 		Dec 2020
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
1 Rev. Ana.
1 EPS Ana. 		Dec 2027
1 Rev. Ana.
1 EPS Ana. 		Dec 2028
1 Rev. Ana.
1 EPS Ana.
Revenue
3.19B
est: 3.22B (-1.2%)
3.46B
est: 3.39B (+2.1%)
3.59B
est: 3.89B (-7.7%)
4.75B
est: 3.22B (+47.2%)
4.88B
est: 3.22B (+51.3%)
3.39B
3.39B – 3.39B
+5.2% YoY
3.89B
3.89B – 3.89B
+14.7% YoY
3.89B
3.89B – 3.89B
+0.0% YoY
EBITDA
364.17M
est: 620.41M (-41.3%)
464.29M
est: 652.56M (-28.9%)
644.78M
est: 748.62M (-13.9%)
995.96M
est: 892.98M (+11.5%)
1.11B
est: 892.98M (+24.8%)
939.25M
939.25M – 939.25M
+5.2% YoY
1.08B
1.08B – 1.08B
+14.7% YoY
1.08B
1.08B – 1.08B
+0.0% YoY
EBIT
140.29M
est: 421.13M (-66.7%)
240.48M
est: 442.95M (-45.7%)
399.75M
est: 508.16M (-21.3%)
698.29M
est: 672.52M (+3.8%)
813.32M
est: 672.52M (+20.9%)
707.37M
707.37M – 707.37M
+5.2% YoY
811.49M
811.49M – 811.49M
+14.7% YoY
811.49M
811.49M – 811.49M
+0.0% YoY
Net Income
71.21M
est: 84.31M (-15.5%)
169.01M
est: 103.04M (+64.0%)
284.29M
est: 243.56M (+16.7%)
489.91M
est: 86.72M (+464.9%)
567.44M
est: 86.72M (+554.3%)
105.99M
105.99M – 105.99M
+22.2% YoY
250.52M
250.52M – 250.52M
+136.4% YoY
250.52M
250.52M – 250.52M
+0.0% YoY
SGA
421.22M
est: 408.14M (+3.2%)
451.70M
est: 429.29M (+5.2%)
502.07M
est: 492.48M (+1.9%)
618.22M
est: 398.06M (+55.3%)
606.04M
est: 398.06M (+52.2%)
418.69M
418.69M – 418.69M
+5.2% YoY
480.32M
480.32M – 480.32M
+14.7% YoY
480.32M
480.32M – 480.32M
+0.0% YoY
EPS
0.43
est: 0.44 (-2.0%)
0.96
est: 0.54 (+79.1%)
1.63
est: 1.27 (+28.6%)
2.71
est: 0.44 (+517.9%)
2.87
est: 0.44 (+554.3%)
0.54
0.54 – 0.54
+22.2% YoY
1.27
1.27 – 1.27
+136.4% YoY
1.27
1.27 – 1.27
+0.0% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-29 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-05-28 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-05-27 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-05-26 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-05-25 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-05-22 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-05-21 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-05-20 C+ 2/5 5/5 1/5 1/5 1/5 3/5 1/5
2026-05-19 C+ 2/5 5/5 1/5 1/5 1/5 3/5 1/5
2026-05-18 C+ 2/5 5/5 1/5 1/5 1/5 3/5 1/5
2026-05-15 C+ 2/5 5/5 1/5 1/5 1/5 3/5 1/5
2026-05-14 A 4/5 5/5 4/5 5/5 2/5 3/5 4/5
2026-05-13 A 4/5 5/5 4/5 5/5 2/5 3/5 4/5
2026-05-12 A 4/5 5/5 4/5 5/5 2/5 3/5 4/5
2026-05-11 A 4/5 5/5 4/5 5/5 2/5 3/5 4/5
2026-05-08 A 4/5 5/5 4/5 5/5 2/5 3/5 4/5
2026-05-07 A 4/5 5/5 4/5 5/5 2/5 3/5 4/5
2026-05-06 A 4/5 5/5 4/5 5/5 2/5 3/5 4/5
2026-05-05 A 4/5 5/5 4/5 5/5 2/5 3/5 4/5
2026-05-04 A 4/5 5/5 4/5 5/5 2/5 3/5 4/5
2026-04-30 A 4/5 5/5 4/5 5/5 2/5 3/5 4/5
2026-04-29 A 4/5 5/5 4/5 5/5 1/5 3/5 4/5
2026-04-28 A 4/5 5/5 4/5 5/5 1/5 3/5 4/5
2026-04-27 A 4/5 5/5 4/5 5/5 1/5 3/5 4/5
2026-04-24 A 4/5 5/5 4/5 5/5 1/5 3/5 4/5
2026-04-23 A- 4/5 5/5 4/5 5/5 1/5 3/5 3/5
2026-04-22 A- 4/5 5/5 4/5 5/5 1/5 3/5 3/5
2026-04-21 A- 4/5 5/5 4/5 5/5 1/5 3/5 3/5
2026-04-20 A- 4/5 5/5 4/5 5/5 1/5 3/5 3/5
2026-04-17 A- 4/5 5/5 4/5 5/5 1/5 3/5 3/5
2026-04-16 A- 4/5 5/5 4/5 5/5 1/5 3/5 3/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
797.78M
OE per share TTM
3.91
Owner's Yield
8.13%
Maintenance CapEx ratio
27.80%
Maint CapEx / Avg PPE
63.4%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 12 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 Avantis Emerging Markets Small Cap Equity ETF AVEE 0.03% 30.2K 0.42%
2 Dimensional - Emerging Markets Value ETF DFEV 0.02% 329.1K 0.46%
3 Avantis Emerging Markets Equity UCITS ETF USD Acc AVEM.L 0.01% 33.2K 0.35%
4 Dimensional - Emerging Markets ex China Core Equity ETF DEXC 0.01% 41.0K 0.56%
5 Dimensional Emerging Markets Sustainability Core 1 ETF DFSE 0.01% 70.5K 0.44%
6 Avantis Responsible Emerging Markets Equity ETF AVSE 0.01% 14.7K 0.33%
7 Avantis Emerging Markets Value ETF AVES 0.01% 83.4K 0.36%
8 Dimensional - Emerging Markets Core Equity 2 ETF DFEM 0.01% 490.1K 0.39%
9 Dimensional - Emerging Core Equity Market ETF DFAE 0.00% 353.2K 0.29%
10 Avantis Emerging Markets ex-China Equity ETF AVXC 0.00% 14.7K 0.33%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
912.8K
Shares Outstanding
196.54M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Tsung-Tien Kuo Chairman & President 12M —
Chung-Sheng Cheng Executive Vice President, Financial Officer & Director 5M male
Kuo-Hsiung Yang Chief Operating Officer 4M male
Bang-Jyun Wang Assistant Vice President of President Office and Information Management Center & CISO — male
Wen-Hui Yu Head of Accounting & Corporate Governance Officer — female
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Chemicals - Specialty